SQUAD CAPITAL INVESTMENT RESEARCH

Independent Investment Research Across Global Markets

Evidence-based company research, rankings and portfolio decisions across Singapore, Japan, Korea and the United States. Every conclusion is dated, price-sensitive and designed to be challenged as facts change.

Research principles

Quality is not enough at any price.

  • Separate business quality from entry valuation.
  • Model the earnings mechanism, not only the narrative.
  • Record disconfirming evidence and thesis breakers.
  • Preserve dated conclusions and revision history.
Published companies10SGX 7 · JPX 1 · KRX 1 · US 1
Markets structured4Singapore · Japan · Korea · United States
Recent research updates12Current repository update log
Last updated16 Aug 2026Dated research, not live market data
CURRENT RESEARCH PRIORITIES

Leading idea or next action by market

SGXActive

Food Empire

Still the best published SGX balance of organic growth and balance-sheet quality, but 1H2026 makes margin and cash conversion the next proof points.

Published base-case IRR11%–14%
Open company research →
JPXActive

Japan Elevator Service Holdings

A high-quality domestic service compounder with a long share-gain runway; accumulation remains price-sensitive because the shares retain a premium multiple.

Published base-case IRR9%–12%
Open company research →
KRXActive

FnGuide

A high-incremental-margin index/data franchise at roughly 9.7x modeled FY2026 earnings, offset by ETF-AUM cyclicality and a real controlling-family governance discount.

Published base-case IRR17%–22%
Open company research →
USActive

S&P Global

An exceptional benchmark and data franchise whose AI risk is concentrated in Market Intelligence interfaces; the current price offers a reasonable but not exceptional return.

Published base-case IRR≈11%
Open company research →
LATEST RESEARCH UPDATES

What changed recently

Open decision journal →
DateMarketSubjectUpdate typeWhat changed
16 Aug 2026KRXFnGuide (064850)New researchActivated Korea coverage with a bottom-up financial-data plus index-royalty model at ₩18,810. The base case normalizes linked ETF AUM below the Q2 peak, treats Value-up as a market-structure tailwind and keeps a governance discount for the Hwacheon/Kwon controlling block.
16 Aug 2026SGXFood Empire 1H2026Valuation refreshRefreshed the company after 15.0% revenue growth and 12.2% normalized NPAT growth. Central Asia strengthened, but operating leverage and cash conversion remain watch items; selective accumulation at S$2.42 with an 11%–14% base-case IRR.
16 Aug 2026SGXFood Empire comparisonsDecision recordedMoved the Sembcorp and UltraGreen comparisons to Needs review because both alternatives have reported since the prior relative conclusions and require common-date refreshes.
2 Aug 2026SGXUltraGreen.ai (ULG / UGS)New researchPublished a normalized ICG-franchise thesis at S$1.53, a current Food Empire comparison, updated SGX ranking and a separate evidence/FAQ note for deeper product and company-history questions.
28 Jul 2026USS&P Global (SPGI)New researchPublished the first current US company page after the Mobility spin and Q2 2026. The broad AI-casualty thesis is rejected, but at $439.83 the base-case five-year IRR is only about 11%.
27 Jul 2026SGXAlpha Integrated REIT 1H2026Valuation refreshUpdated the thesis at S$0.520 after 95.0% occupancy, 10.8% NPI growth, 10.4% distributable-income growth and lower financing cost. Headline DPU growth was normalised for prior-period retention.
22 Jul 2026JPXJapan Elevator Service Holdings (6544)New researchPublished the first current Japan company page with contract-growth economics, modernization, margin leverage, historical valuation, OEM competition and scenario returns at ¥1,677.5.
19 Jul 2026Cross-marketComparison libraryFramework updateAdded schema-validated studies, search and filters, permanent current-study routes and a needs-review migration queue.
19 Jul 2026SGXAll six company pagesFramework updateRebuilt earnings drivers, evidence for and against each thesis, and thesis-critical monitoring.
19 Jul 2026SGXCurrent rankingsDecision recordedSeparated price-sensitive rankings from permanent comparison studies.
19 Jul 2026SGXFood Empire vs SembcorpComparison addedCompared organic compounding and net cash with acquisition-led utility growth and leverage risk.
19 Jul 2026SGXIndustrial REIT basketComparison addedCompared Alpha, Stoneweg and AIMS using DPU, NPI, leverage, financing coverage and valuation.
CURRENT RANKINGS

Market-specific capital allocation

View full rankings →
SGX

Singapore ranking

Active
RankCompanyBase IRRView
1Food Empire11%–14%Accumulate selectively
2Sembcorp Industries12%–16%Accumulate
3UltraGreen.ai10%–14%Accumulate selectively
View complete SGX ranking →
JPX

Japan ranking

Coverage active

Japan Elevator Service Holdings is published as current research, but a one-company ranking is intentionally withheld.

  • Refresh more Japan candidates
  • Align price and forecast dates
  • Apply consistent normalization and scores
Open Japan research →
KRX

Korea ranking

Coverage active

FnGuide is published as current research, but it is not labelled rank 1 because one company cannot form a capital-allocation ranking.

  • Refresh more Korea candidates
  • Apply a common Value-up and governance framework
  • Normalize earnings and excess cash consistently
Open Korea research →
US

United States ranking

Coverage active

S&P Global is published as current research, but it is not labelled rank 1 because one company cannot form a capital-allocation ranking.

  • Refresh more US candidates
  • Use a common price date
  • Normalize earnings and free cash flow consistently
Open US research →
FEATURED COMPANY RESEARCH

One editorial slot per market

Browse company library →
DECISION JOURNAL

Latest recorded decisions

FnGuide activates Korea coverage; A+ withheld

Accumulate selectively at ₩18,810 with a 17%–22% modeled base-case IRR. The business has become a high-incremental-margin index/data franchise, but the controlling Hwacheon/Kwon family receives a governance and minority-capital-return discount, so the company is not yet classified A+.

Food Empire retains SGX rank one with a narrower return cushion

1H2026 keeps the growth thesis intact but does not yet prove operating leverage. The view moves to Accumulate selectively at S$2.42 with an 11%–14% base-case IRR; Kazakhstan contribution, margin recovery and cash conversion are the next gates.

Stale Food Empire relative conclusions withheld

The Sembcorp and UltraGreen comparisons move to Needs review because both alternatives have released new results. The old Food Empire preference is preserved in revision history but not presented as current.

UltraGreen enters SGX coverage; software remains optionality

Accumulate selectively at S$1.53 with a 10%–14% base IRR. The core case rests on regulated ICG consumables, volume, pricing and net cash; no material software value is assumed before paying sites and revenue are disclosed.

S&P Global becomes the first current US company

The view is Watch / selective accumulation at $439.83. Q2 2026 weakens the broad AI-casualty case, but a roughly 25x forward adjusted P/E produces only about an 11% base-case five-year IRR.

Alpha recovery validated; valuation now matters more

The view changes from Await results to Accumulate selectively at S$0.520, preferably below S$0.50 ex-distribution. The base case is a 10%–12% IRR from yield and modest DPU growth rather than a large NAV rerating.

Japan Elevator Service becomes the first current JPX company

The view is Accumulate selectively at ¥1,677.5, with a 9%–12% base-case IRR and a 34–36x exit framework. A one-company Japan ranking is intentionally withheld.

Comparison migration separated from publication

Old chat comparisons can enter the searchable queue without carrying an outdated conclusion into the public site.

Food Empire retained as the leading published SGX idea

Organic growth and net cash currently outweigh concentration risk at the dated valuation.

Rankings and comparisons separated

Rankings answer where capital is most attractive; comparison studies explain why one investment is preferred.

Open full journal →
METHODOLOGY

Scores organise judgment; they do not replace valuation.

Business quality 25%Growth & operating leverage 20%Valuation 20%Capital allocation 15%Downside protection 10%Thesis clarity 10%

A high-quality company can still rank poorly at an excessive price.

Read methodology →